• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新生儿心力衰竭与黏多糖贮积症所致的心肌致密化不全/扩张型心肌病。文献首次描述。

Neonatal heart failure and noncompaction/dilated cardiomyopathy from mucopolysaccharidosis. First description in literature.

作者信息

Miselli Francesca, Brambilla Alice, Calabri Giovanni Battista, Favilli Silvia, Sanvito Maria Chiara, Ragni Luca, Torcetta Francesco, Rossi Katia, Donati Maria Alice, Procopio Elena

机构信息

Department of Health Sciences, University of Florence, Viale Pieraccini 6 -, 50139 Florence, Italy.

Paediatric Cardiology Unit, Meyer Children Hospital, Viale Pieraccini 24, 50139 Florence, Italy.

出版信息

Mol Genet Metab Rep. 2021 Jan 29;26:100714. doi: 10.1016/j.ymgmr.2021.100714. eCollection 2021 Mar.

DOI:10.1016/j.ymgmr.2021.100714
PMID:33552908
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7851837/
Abstract

Mucopolysaccharidosis are genetic disorders due to deficiency of lysosomal enzymes, resulting in abnormal glycosaminoglycans accumulation in several tissues. Heart involvement tends to be progressive and worsens with age. We describe the first case of mucopolysaccharidosis type I presenting with noncompaction/dilated-mixed cardiomyopathy and heart failure within neonatal period, which responded successfully to specific metabolic treatment. Cardiac function recovered after enzyme replacement therapy and hematopoietic stem cell transplantation, adding to the existing knowledge of the disease.

摘要

黏多糖贮积症是由于溶酶体酶缺乏导致的遗传性疾病,会致使几种组织中异常糖胺聚糖蓄积。心脏受累往往呈进行性,且会随着年龄增长而恶化。我们描述了首例在新生儿期表现为心肌致密化不全/扩张型混合性心肌病和心力衰竭的Ⅰ型黏多糖贮积症病例,该病例对特定代谢治疗反应良好。酶替代疗法和造血干细胞移植后心脏功能得以恢复,这丰富了该疾病的现有认知。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84ab/7851837/2339cd7701cb/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84ab/7851837/2339cd7701cb/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84ab/7851837/2339cd7701cb/gr1.jpg

相似文献

1
Neonatal heart failure and noncompaction/dilated cardiomyopathy from mucopolysaccharidosis. First description in literature.新生儿心力衰竭与黏多糖贮积症所致的心肌致密化不全/扩张型心肌病。文献首次描述。
Mol Genet Metab Rep. 2021 Jan 29;26:100714. doi: 10.1016/j.ymgmr.2021.100714. eCollection 2021 Mar.
2
Early Neonatal Cardiac Phenotype in Hurler Syndrome: Case Report and Literature Review.Hurler 综合征的新生儿早期心脏表型:病例报告及文献复习。
Genes (Basel). 2022 Jul 22;13(8):1293. doi: 10.3390/genes13081293.
3
Early enzyme replacement therapy enables a successful hematopoietic stem cell transplantation in mucopolysaccharidosis type IH: Divergent clinical outcomes in two Japanese siblings.早期酶替代疗法可使Ⅰ型黏多糖贮积症成功进行造血干细胞移植:两名日本兄妹的不同临床结局
Brain Dev. 2019 Jun;41(6):546-550. doi: 10.1016/j.braindev.2019.01.008. Epub 2019 Feb 10.
4
Mucopolysaccharidosis type I.I型黏多糖贮积症
Pediatr Endocrinol Rev. 2014 Sep;12 Suppl 1:102-6.
5
Enzyme replacement therapy (ERT) procedure for mucopolysaccharidosis type II (MPS II) by intraventricular administration (IVA) in murine MPS II.经脑室给药(IVA)治疗黏多糖贮积症 II 型(MPS II)的酶替代疗法(ERT)在 MPS II 小鼠中的应用。
Mol Genet Metab. 2012 Sep;107(1-2):122-8. doi: 10.1016/j.ymgme.2012.05.005. Epub 2012 May 18.
6
Hematopoietic cell transplantation for Mucopolysaccharidosis I in the presence of decreased cardiac function.心功能降低情况下黏多糖贮积症I型的造血细胞移植
Mol Genet Metab. 2023 Nov;140(3):107669. doi: 10.1016/j.ymgme.2023.107669. Epub 2023 Jul 27.
7
Management of mucopolysaccharidosis type IH (Hurler's syndrome) presenting in infancy with severe dilated cardiomyopathy: a single institution's experience.婴儿期起病且伴有严重扩张型心肌病的黏多糖贮积症 IH 型(胡尔勒综合征)的治疗:单中心经验。
J Inherit Metab Dis. 2013 Mar;36(2):263-70. doi: 10.1007/s10545-012-9500-3. Epub 2012 Jun 21.
8
Mucopolysaccharidosis: What Pediatric Rheumatologists and Orthopedics Need to Know.黏多糖贮积症:儿科风湿病学家和骨科医生需要了解的内容。
Diagnostics (Basel). 2022 Dec 27;13(1):75. doi: 10.3390/diagnostics13010075.
9
Effectiveness of Early Hematopoietic Stem Cell Transplantation in Preventing Neurocognitive Decline in Mucopolysaccharidosis Type II: A Case Series.早期造血干细胞移植预防II型黏多糖贮积症神经认知功能衰退的有效性:病例系列研究
JIMD Rep. 2018;41:81-89. doi: 10.1007/8904_2018_104. Epub 2018 Apr 19.
10
Hematopoietic Stem Cell Transplantation for Patients with Mucopolysaccharidosis II.黏多糖贮积症 II 患者的造血干细胞移植。
Biol Blood Marrow Transplant. 2017 Oct;23(10):1795-1803. doi: 10.1016/j.bbmt.2017.06.020. Epub 2017 Jul 1.

引用本文的文献

1
Early Neonatal Cardiac Phenotype in Hurler Syndrome: Case Report and Literature Review.Hurler 综合征的新生儿早期心脏表型:病例报告及文献复习。
Genes (Basel). 2022 Jul 22;13(8):1293. doi: 10.3390/genes13081293.
2
Pre-operative Considerations in Adult Mucopolysaccharidosis Patients Planned for Cardiac Intervention.计划进行心脏介入治疗的成年黏多糖贮积症患者的术前注意事项。
Front Cardiovasc Med. 2022 Apr 4;9:851016. doi: 10.3389/fcvm.2022.851016. eCollection 2022.

本文引用的文献

1
Genetic Infiltrative Cardiomyopathies.遗传性浸润性心肌病
Heart Fail Clin. 2018 Apr;14(2):215-224. doi: 10.1016/j.hfc.2017.12.003.
2
Cardiac manifestations of inherited metabolic disease in children.儿童遗传性代谢疾病的心脏表现
Pediatr Int. 2017 May;59(5):525-529. doi: 10.1111/ped.13272.
3
Left Ventricular Noncompaction: A Distinct Genetic Cardiomyopathy?左心室心肌致密化不全:一种独特的遗传性心肌病?
J Am Coll Cardiol. 2016 Aug 30;68(9):949-66. doi: 10.1016/j.jacc.2016.05.096.
4
Mitochondrial Cardiomyopathies.线粒体心肌病。
Front Cardiovasc Med. 2016 Jul 25;3:25. doi: 10.3389/fcvm.2016.00025. eCollection 2016.
5
Residual α-L-iduronidase activity in fibroblasts of mild to severe Mucopolysaccharidosis type I patients.黏多糖贮积症 I 型患者的成纤维细胞中残留的α-L-艾杜糖苷酸酶活性。
Mol Genet Metab. 2013 Aug;109(4):377-81. doi: 10.1016/j.ymgme.2013.05.016. Epub 2013 Jun 4.
6
Management of mucopolysaccharidosis type IH (Hurler's syndrome) presenting in infancy with severe dilated cardiomyopathy: a single institution's experience.婴儿期起病且伴有严重扩张型心肌病的黏多糖贮积症 IH 型(胡尔勒综合征)的治疗:单中心经验。
J Inherit Metab Dis. 2013 Mar;36(2):263-70. doi: 10.1007/s10545-012-9500-3. Epub 2012 Jun 21.
7
Mucopolysaccharidosis: cardiologic features and effects of enzyme-replacement therapy in 24 children with MPS I, II and VI.黏多糖贮积症:24 例黏多糖贮积症 I、II 和 VI 型患儿的心脏特征及酶替代治疗的效果。
J Inherit Metab Dis. 2013 Mar;36(2):227-34. doi: 10.1007/s10545-011-9444-z. Epub 2012 Jan 26.
8
Cardiac disease in patients with mucopolysaccharidosis: presentation, diagnosis and management.黏多糖贮积症患者的心脏疾病:临床表现、诊断与治疗。
J Inherit Metab Dis. 2011 Dec;34(6):1183-97. doi: 10.1007/s10545-011-9359-8. Epub 2011 Jul 9.
9
Fatal coronary artery disease in an infant with severe mucopolysaccharidosis type I.婴儿重症黏多糖贮积症Ⅰ型合并致死性冠状动脉疾病
Pediatrics. 2011 May;127(5):e1343-6. doi: 10.1542/peds.2009-2047. Epub 2011 Apr 4.
10
Guidelines for the management of mucopolysaccharidosis type I.I型黏多糖贮积症管理指南。
J Pediatr. 2009 Oct;155(4 Suppl):S32-46. doi: 10.1016/j.jpeds.2009.07.005.